Publications
-
An uncommon complication of percutaneous endoscopic gastrostomy tubes.
Wong R,
Ladabaum U.
Clin Gastroenterol Hepatol.
2013;
11
(2):
xxv
-
Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN,
Ladabaum U.
Am J Gastroenterol.
2013;
108
(1):
120-32
-
Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities.
Jandorf L,
Stossel LM, Cooperman JL, Graff Zivin J, Ladabaum U, Hall D, Thélémaque LD, Redd W, Itzkowitz SH.
Cancer.
2013;
119
(3):
612-20
-
Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer.
Dinh T,
Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.
Clin Gastroenterol Hepatol.
2013
-
How to value technological innovation: a proposal for determining relative clinical value.
Ladabaum U,
Brill JV, Sonnenberg A, Shaheen NJ, Inadomi J, Wilcox CM, Park WG, Hur C, Pasricha PJ.
Gastroenterology.
2013;
144
(1):
5-8
-
Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome.
Kuppermann M,
Wang G, Wong S, Blanco A, Conrad P, Nakagawa S, Terdiman J, Ladabaum U.
Cancer.
2013;
119
(1):
215-25
-
Real-time optical biopsy of colon polyps with narrow band imaging in community practice does not yet meet key thresholds for clinical decisions.
Ladabaum U,
Fioritto A, Mitani A, Desai M, Kim JP, Rex DK, Imperiale T, Gunaratnam N.
Gastroenterology.
2013;
144
(1):
81-91
-
Uptake of Genetic Testing by Relatives of Lynch Syndrome Probands: a Systematic Review.
Sharaf RN,
Myer P, Stave CD, Diamond LC, Ladabaum U.
Clin Gastroenterol Hepatol.
2013
-
Cancer-associated aorto-enteric fistula.
Singh S,
Ladabaum U, Hovsepian DM, Triadafilopoulos G.
Dig Dis Sci.
2012;
57
(3):
625-9
-
Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization.
Ladabaum U,
Boyd E, Zhao WK, Mannalithara A, Sharabidze A, Singh G, Chung E, Levin TR.
Clin Gastroenterol Hepatol.
2012;
10
(1):
37-45
-
Disparities in cancer screening in individuals with a family history of breast or colorectal cancer.
Ponce NA,
Tsui J, Knight SJ, Afable-Munsuz A, Ladabaum U, Hiatt RA, Haas JS.
Cancer.
2012;
118
(6):
1656-63
-
Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.
Wang G,
Kuppermann M, Kim B, Phillips KA, Ladabaum U.
Am J Manag Care.
2012;
18
(5):
e179-85
-
Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome.
Wang G,
Kuppermann M, Kim B, Phillips KA, Ladabaum U.
J Oncol Pract.
2012;
8
(3 Suppl):
e24s-30s
-
Lynch syndrome in patients with colorectal cancer: finding the needle in the haystack.
Ladabaum U,
Ford JM.
JAMA.
2012;
308
(15):
1581-3
-
Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians.
Walsh J,
Arora M, Hosenfeld C, Ladabaum U, Kuppermann M, Knight SJ.
J Cancer Educ.
2012;
27
(1):
112-9
-
Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy.
Myer PA,
Mannalithara A, Singh G, Ladabaum U.
Gastroenterology.
2012;
143
(5):
1227-36
-
Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
Ladabaum U,
Cheng SL, Yao FY, Roberts JP.
Clin Transplant.
2011 Mar-Apr;
25
(2):
283-91
-
Economic evaluation of targeted cancer interventions: critical review and recommendations.
Elkin EB,
Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA.
Genet Med.
2011;
13
(10):
853-60
-
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Ladabaum U,
Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.
Ann Intern Med.
2011;
155
(2):
69-79
-
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps.
Rex DK,
Kahi C, O'Brien M, Levin TR, Pohl H, Rastogi A, Burgart L, Imperiale T, Ladabaum U, Cohen J, Lieberman DA.
Gastrointest Endosc.
2011;
73
(3):
419-22
-
Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.
Ladabaum U,
Sharabidze A, Levin TR, Zhao WK, Chung E, Bacchetti P, Jin C, Grimes B, Pepin CJ.
Clin Gastroenterol Hepatol.
2010;
8
(1):
42-48.e1
-
Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.
Ladabaum U,
Ferrandez A, Lanas A.
Cancer Epidemiol Biomarkers Prev.
2010;
19
(11):
2765-76
-
Esophageal verrucous carcinoma arising from hyperkeratotic plaques associated with human papilloma virus type 51.
Tonna J,
Palefsky JM, Rabban J, Campos GM, Theodore P, Ladabaum U.
Dis Esophagus.
2010;
23
(5):
E17-20
-
Rate and yield of repeat upper endoscopy in patients with dyspepsia.
Ladabaum U,
Dinh V.
World J Gastroenterol.
2010;
16
(20):
2520-5
-
Addressing the challenges of the clinical application of pharmacogenetic testing.
Ikediobi ON,
Shin J, Nussbaum RL, Phillips KA, Walsh JM, Ladabaum U, Marshall D.
Clin Pharmacol Ther.
2009;
86
(1):
28-31
-
Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?
Shaukat A,
Parekh M, Lipscomb J, Ladabaum U.
Int J Technol Assess Health Care.
2009;
25
(2):
222-31
-
Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates.
Rubenstein JH,
Waljee AK, Jeter JM, Velayos FS, Ladabaum U, Higgins PD.
Am J Gastroenterol.
2009;
104
(9):
2222-32
-
Melanosis coli.
Li D,
Browne LW, Ladabaum U.
Clin Gastroenterol Hepatol.
2009;
7
(9):
A20
-
As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.
Parekh M,
Fendrick AM, Ladabaum U.
Aliment Pharmacol Ther.
2008;
27
(8):
697-712
-
Colonoscopic treatment of acute diverticular hemorrhage using endoclips.
Yen EF,
Ladabaum U, Muthusamy VR, Cello JP, McQuaid KR, Shah JN.
Dig Dis Sci.
2008;
53
(9):
2480-5
-
Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis.
Yen EF,
Kane SV, Ladabaum U.
Am J Gastroenterol.
2008;
103
(12):
3094-105
-
Gastric fundic distension activates fronto-limbic structures but not primary somatosensory cortex: a functional magnetic resonance imaging study.
Ladabaum U,
Roberts TP, McGonigle DJ.
Neuroimage.
2007;
34
(2):
724-32
-
Trends in colonoscopy for colorectal cancer screening.
Phillips KA,
Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL.
Med Care.
2007;
45
(2):
160-7
-
When even people at high risk do not take up colorectal cancer screening.
Ladabaum U,
Gut.
2007;
56
(12):
1648-50
-
A patient with high risk of gastrointestinal bleeding requiring nonsteroidal anti-inflammatory drugs.
Wilcox CM,
Ladabaum U.
Clin Gastroenterol Hepatol.
2006;
4
(9):
1090-3
-
Colorectal cancer screening differential costs for younger versus older Americans.
Ladabaum U,
Phillips KA.
Am J Prev Med.
2006;
30
(5):
378-84
-
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
Wilcox CM, Allison J, Benzuly K, Borum M, Cryer B, Grosser T, Hunt R, Ladabaum U, Lanas A, Paulus H, Regueiro C, Sandler RS, Simon L.
Clin Gastroenterol Hepatol.
2006;
4
(9):
1082-9
-
Rates and predictors of colorectal cancer screening.
Liang SY,
Phillips KA, Nagamine M, Ladabaum U, Haas JS.
Prev Chronic Dis.
2006;
3
(4):
A117
-
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
Patel D,
Terrault NA, Yao FY, Bass NM, Ladabaum U.
Clin Gastroenterol Hepatol.
2005;
3
(1):
75-84
-
Obstipation as a paraneoplastic presentation of small cell lung cancer: case report and literature review.
Jun S,
Dimyan M, Jones KD, Ladabaum U.
Neurogastroenterol Motil.
2005;
17
(1):
16-22
-
Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
Ladabaum U,
Song K.
Gastroenterology.
2005;
129
(4):
1151-62
-
Sedation for gastrointestinal endoscopy: new practices, new economics.
Aisenberg J,
Brill JV, Ladabaum U, Cohen LB.
Am J Gastroenterol.
2005;
100
(5):
996-1000
-
Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?
Ladabaum U,
Song K, Fendrick AM.
Clin Gastroenterol Hepatol.
2004;
2
(7):
554-63
-
Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
Song K,
Fendrick AM, Ladabaum U.
Gastroenterology.
2004;
126
(5):
1270-9
-
Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis.
Mein SM,
Ladabaum U.
Aliment Pharmacol Ther.
2004;
19
(11):
1199-210
-
Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
Kruspe R,
Lillis R, Daberkow DW, Blais CM, Wilbright W, Gupta S, Gould CA, Sun T, Martinez JA, deBoisblanc B, Ladabaum U, Sanders CV, Lopez FA.
J La State Med Soc.
2003 Nov-Dec;
155
(6):
325-31
-
Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs.
Ladabaum U,
Expert Rev Pharmacoecon Outcomes Res.
2003;
3
(6):
757-71
-
Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.
Ladabaum U,
Scheiman JM, Fendrick AM.
Am J Med.
2003;
114
(7):
546-54
-
Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications.
Ladabaum U,
Aliment Pharmacol Ther.
2003;
17
(8):
1021-30
-
Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans.
Ladabaum U,
Glidden D.
Neurogastroenterol Motil.
2002;
14
(4):
395-402
-
Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States.
Ladabaum U,
Fendrick AM, Glidden D, Scheiman JM.
Am J Gastroenterol.
2002;
97
(12):
3007-14
-
Positron emission tomography: the gastroenterologists's perspective.
Ladabaum U,
Gastrointest Endosc.
2002;
55
(7 Suppl):
S64-6
-
Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Ladabaum U,
Chey WD, Scheiman JM, Fendrick AM.
Aliment Pharmacol Ther.
2002;
16
(8):
1491-501
-
The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center.
Pepin C,
Ladabaum U.
Gastrointest Endosc.
2002;
56
(3):
325-32
-
Uninvestigated Dyspepsia.
Ladabaum U,
Chey WD.
Curr Treat Options Gastroenterol.
2002;
5
(2):
125-131
-
Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
Ladabaum U,
Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.
Ann Intern Med.
2001;
135
(9):
769-81
-
Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans.
Ladabaum U,
Brown MB, Pan W, Owyang C, Hasler WL.
Am J Physiol Gastrointest Liver Physiol.
2001;
280
(2):
G201-8
-
Gastric distention correlates with activation of multiple cortical and subcortical regions.
Ladabaum U,
Minoshima S, Hasler WL, Cross D, Chey WD, Owyang C.
Gastroenterology.
2001;
120
(2):
369-76
-
Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsia.
Ladabaum U,
Fendrick AM, Scheiman JM.
Am J Gastroenterol.
2001;
96
(7):
2051-7
-
Pathobiology of visceral pain: molecular mechanisms and therapeutic implications V. Central nervous system processing of somatic and visceral sensory signals.
Ladabaum U,
Minoshima S, Owyang C.
Am J Physiol Gastrointest Liver Physiol.
2000;
279
(1):
G1-6
-
Images in clinical medicine. Barrett's esophagus with high-grade dysplasia.
Ladabaum U,
McDonnell WM.
N Engl J Med.
1999;
341
(19):
1439
-
Motility of the small intestine.
Ladabaum U,
Hasler WL.
Curr Opin Gastroenterol.
1999;
15
(2):
125-31
-
Novel approaches to the treatment of nausea and vomiting.
Ladabaum U,
Hasler WL.
Dig Dis.
1999;
17
(3):
125-32
-
Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex.
Björnsson ES,
Chey WD, Ladabaum U, Woods ML, Hooper FG, Owyang C, Hasler WL.
Am J Physiol.
1998;
275
(3 Pt 1):
G498-505
-
Differential symptomatic and electrogastrographic effects of distal and proximal human gastric distension.
Ladabaum U,
Koshy SS, Woods ML, Hooper FG, Owyang C, Hasler WL.
Am J Physiol.
1998;
275
(3 Pt 1):
G418-24
-
Potential population-wide impact of aspirin on colon cancer mortality.
Ladabaum U,
Sowers M.
Gastroenterology.
1998;
115
(2):
514-5
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help